MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 5,280.00
-210.00 (-3.83%)
Apr 29, 2026, 3:30 PM KST
MedPacto Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 |
Depreciation & Amortization | 1,156 | 1,542 | 1,833 | 1,866 | 1,723 |
Loss (Gain) From Sale of Assets | 23.57 | - | 5.93 | - | - |
Loss (Gain) From Sale of Investments | -219.96 | -554.71 | -350.51 | -1,018 | -627.44 |
Loss (Gain) on Equity Investments | 267.33 | 452.51 | 390.44 | 525.38 | 361.1 |
Stock-Based Compensation | 1,057 | 697.5 | 1,040 | 2,375 | 2,745 |
Provision & Write-off of Bad Debts | - | -9.1 | -5.9 | - | - |
Other Operating Activities | 167.05 | -222.6 | 6,305 | 141.08 | -11,453 |
Change in Accounts Receivable | -1,665 | - | - | - | - |
Change in Inventory | -646.15 | - | - | - | - |
Change in Accounts Payable | 73.35 | - | - | - | - |
Change in Other Net Operating Assets | -792.11 | 1,676 | -193.16 | 2,249 | -861.82 |
Operating Cash Flow | -13,390 | -16,559 | -26,301 | -29,614 | -25,153 |
Capital Expenditures | -91.25 | -313.89 | -100.64 | -877.63 | -756.56 |
Sale (Purchase) of Intangibles | -151.84 | -8.78 | -72.27 | -47.4 | -152.31 |
Investment in Securities | 11,988 | -39,915 | 96,949 | 26,769 | -76,777 |
Other Investing Activities | -100 | -0 | -249.88 | -80.91 | -80.24 |
Investing Cash Flow | 11,024 | -40,237 | 96,526 | 25,763 | -77,766 |
Short-Term Debt Issued | - | - | 1,000 | - | 35.49 |
Long-Term Debt Issued | - | - | - | - | 70,000 |
Total Debt Issued | - | - | 1,000 | - | 70,035 |
Short-Term Debt Repaid | - | - | -1,000 | - | -35.49 |
Long-Term Debt Repaid | -635.09 | -843.82 | -70,816 | -503.18 | -485.19 |
Total Debt Repaid | -635.09 | -843.82 | -71,816 | -503.18 | -520.69 |
Net Debt Issued (Repaid) | -635.09 | -843.82 | -70,816 | -503.18 | 69,515 |
Issuance of Common Stock | - | - | 72,844 | 3,401 | 1,974 |
Other Financing Activities | - | - | -15.02 | - | 34 |
Financing Cash Flow | -635.09 | -843.82 | 2,014 | 2,898 | 101,523 |
Foreign Exchange Rate Adjustments | -10.92 | 45.57 | 5.92 | 19.59 | -2.78 |
Net Cash Flow | -3,012 | -57,595 | 72,244 | -933.04 | -1,399 |
Free Cash Flow | -13,481 | -16,873 | -26,402 | -30,491 | -25,909 |
Free Cash Flow Margin | -345.80% | - | - | - | - |
Free Cash Flow Per Share | -393.57 | -500.99 | -1244.33 | -916.79 | -1265.52 |
Cash Interest Paid | - | - | 1,418 | - | - |
Cash Income Tax Paid | -116.11 | 138.25 | -124.39 | 123.19 | 100.05 |
Levered Free Cash Flow | -10,491 | -11,213 | -20,379 | -21,300 | -23,447 |
Unlevered Free Cash Flow | -10,418 | -11,155 | -20,070 | -15,288 | -18,592 |
Change in Working Capital | -3,030 | 1,676 | -193.16 | 2,249 | -861.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.